Hong Kong needs cervical screening, say doctors:
This article was originally published in Clinica
Doctors in Hong Kong have called for the introduction of an organised cervical screening programme targeted at high-risk groups, reports the South China Morning Post. Only around 20% of women in Hong Kong undergo regular smear tests, compared with 70% in the US and nearly 80% in Europe. Cervical cancer is striking at an increasingly early age in Hong Kong. The mean age at diagnosis fell from 56.7 in 1992 to 49.9 last year and almost 62% of sufferers are now aged under 50.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.